Scientific Challenges in Postmarketing Surveillance of Ocular Adverse Drug Reactions

American Journal of Ophthalmology

Volumn 143, Issue 1, 2007, Pages

  Fraunfelder, Frederick W ^a   Fraunfelder, Frederick T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CHLORAMPHENICOL; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

APLASTIC ANEMIA; ARTICLE; BLOOD DYSCRASIA; CONJUNCTIVITIS; DATA BASE; DISK EDEMA; DRUG EFFICACY; EDEMA; EYE INFECTION; EYE TOXICITY; HUMAN; ISCHEMIC OPTIC NEUROPATHY; NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY; NONARTERITIS ANTERIOR ISCHEMIC OPTIC NEUROPATHY; OPTIC NERVE DISEASE; PEER REVIEW; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; VISUAL DISORDER; VISUAL IMPAIRMENT;

EID: 33845489157     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.10.005     Document Type: Article

References (31)

1. McDonnell P.J. Are you skeptical of the latest peer-reviewed results?. You should be; one-third of claims are later found to be wrong. Ophthalmology Times (2006) 4 February 15
2. Ioannidis J.P. Why most published research findings are false. PLoS Med 2 (2005) e124 Aug; Epub August 30, 2005.
3. Scientific accuracy ... and statistics. Just how reliable are scientific papers?. The Economist (2005) 72 September 3
4. Edwards R., and Biriell C. Harmonisation in pharmacovigilance. Drug Saf 10 (1994) 93-102
5. Pomeranz H.D., and Bhavsar A.R. Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (Viagra): a report of seven new cases. J Neuroophthalmol 25 (2005) 9-13
6. Gandhi J.S. Sildenafil-associated NAION. Ophthalmology 110 (2003) 1860-1861
7. Pomeranz H.D., Smith K.H., Hart Jr. W.M., and Egan R.A. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 109 (2002) 584-587
8. Cunningham A.V., and Smith K.H. Anterior ischemic optic neuropathy associated with Viagra. J Neuroophthalmol 21 (2001) 22-25
9. Egan R., and Pomeranz H. Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol 118 (2000) 291-292
10. Fraunfelder F.W. An overview of visual side effects associated with erectile dysfunction agents. Am J Ophthalmol 140 (2005) 723-724
11. Fraunfelder F.W., and Shults W.T. Nonarteritic anterior ischemic optic neuropathy, erectile dysfunction drugs, and amiodarone: Is there a relationship?. J Neuroophthalmol 26 (2006) 1-3
12. Hayreh S.S. Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy: is there a cause and effect relationship?. J Neuroophthalmol 25 (2005) 295-298
13. Morgan J.C., Alhatou M., Oberlves J., et al. Transient ischemic attack and stroke associated with sildenafil use. Neurology 57 (2001) 1730-1731
14. th ed.) (2002), Medical Economics Company, Montvale, New Jersey, USA 2552-2556
15. Murphy M.A., and Murphy J.F. Amiodarone and optic neuropathy: the heart of the matter. J Neuroophthalmol 25 (2005) 232-236
16. Macaluso D.C., Shults W.T., and Fraunfelder F.T. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol 127 (1999) 610-612
17. Feiner L.A., Younge B.R., Kazmier F.J., et al. Optic neuropathy and amiodarone therapy. Mayo Clin Proc 62 (1987) 702-717
18. Fraunfelder F.T., and Fraunfelder F.W. Drug-induced ocular side effects. 5th ed. (2001), Butterworth-Heinemann, Woburn, MA
19. Mansour A.M., Puklin J.E., and O'Grady R. Optic nerve ultrastructure following amiodarone therapy. J Clin Neuroophthalmol 8 (1988) 231-237
20. Purvin V., Kawasaki A., and Bourruat F.X. Optic neuropathy in patients using amiodarone. Arch Ophthalmol 124 (2006) 696-701
21. Roberts M. 22 million damage award to blind man will stand. Oregonian (2000) C1-C5 January 25
22. Ursell P. Widespread use of topical chloramphenicol. Br J Ophthalmol 80 (1996) 854
23. McGhee C.N., and Anastas C.N. Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anemia?. Br J Ophthalmol 80 (1996) 182-184
24. Lam R.F., Lai J.S., Ng J.S., Rao S.K., et al. Topical chloramphenicol for eye infections. Hong Kong Med J 8 (2002) 44-47
25. Doona M., and Walsh J.B. Use of chloramphenicol as topical eye medication: time to cry halt?. BMJ 310 (1995) 1217-1218
26. Fraunfelder F.T., Morgan R.L., and Yunis A.A. Blood dyscrasias and topical ophthalmic chloramphenicol. Am J Ophthalmol 115 (1993) 812-813
27. Fraunfelder F.T., and Bagby G.C. Ocular chloramphenicol and aplastic anemia. N Engl J Med 308 (1983) 1536
28. Fraunfelder F.T. Fatal aplastic anemia. JAMA 247 (1982) 2499
29. Walker S., Diaper C.J., Bowman R., et al. Lack of evidence for systemic toxicity following topical chloramphenicol use. Eye 12 (1998) 875-879
30. Bettman J.W. Seven hundred medicolegal cases in ophthalmology. Ophthalmology 97 (1990) 1379-1384
31. Brick D.C. Medication errors result in costly claims for ophthalmologists. Surv Ophthalmol 40 (1995) 232-236